News Focus
News Focus
icon url

DewDiligence

06/28/18 1:27 PM

#219854 RE: DewDiligence #213243

Microcap COCP still seeking 6wk HCV regimen:

https://finance.yahoo.com/news/cocrystal-pharma-commences-enrollment-initiates-113500375.html

In this single-arm phase-2 trial, patients will get 2 weeks of COCP’s non-nuke, CC-31244 with GILD’s SOF/VEL, then 4 weeks of SOF/VEL alone. COCP does not have a collaborative agreement with GILD, as far as I know.